Risk factors for high-risk human papillomavirus infection and cofactors for high-grade cervical disease in Peru

International Journal of Gynecological Cancer

Volumn 21, Issue 9, 2011, Pages 1654-1663

  Almonte, Maribel ^a   Ferreccio, Catterina ^b   Gonzales, Miguel ^c,d   Delgado, Jose Manuel ^d,e   Buckley, C Hilary ^f   Luciani, Silvana ^d   Robles, Sylvia C ^d   Winkler, Jennifer L ^g   Tsu, Vivien D ^g   Jeronimo, Jose ^g   Cuzick, Jack ^a   Sasieni, Peter ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c Dirección Regional de Salud DIRES San Martin   (Peru)

^d PAN AMERICAN HEALTH ORGANIZATION   (United States)

^e Universidad Nacional de San Martin   (Peru)

^f ST MARY S HOSPITAL   (United Kingdom)

^g PATH   (United States)

Author keywords

Cervical cancer; Cervical screening; Human papillomavirus; Risk factors

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER GRADING; CANCER RISK; CANCER SCREENING; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PARITY; PERU; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SEXUAL INTERCOURSE; SEXUALITY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; MIDDLE AGED; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIROLOGY;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PERU; PREVALENCE; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84857415504     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e3182288104     Document Type: Article

References (24)

1. Ferlay J, Shin H, Bray F, et al. GLOBOCAN 2008. Cancer Incidence and Mortality Worldwide. IARC CancerBase No. 10. 2010.
2. Muñoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-527. (Pubitemid 36159887)
3. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-19. (Pubitemid 29406813)
4. Bosch FX, Burchell AN, Schiffman M, et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine. 2008;26(suppl 10):K1-K16.
5. Plummer M, Schiffman M, Castle PE, et al. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis. 2007;195:1582-1589. (Pubitemid 46799215)
6. Schiffman M, Kjaer SK. Chapter 2: natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr. 2003:31:14-19.
7. Almonte M, Albero G, Molano M, et al. Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean. Vaccine. 2008;26(suppl 11):L16-L36.
8. Vaccarella S, Franceschi S, Herrero R, et al. Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys. Cancer Epidemiol Biomarkers Prev. 2006;15:326-333. (Pubitemid 43342183)
9. Vaccarella S, Herrero R, Snijders PJ, et al. Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. Int J Epidemiol. 2008;37:536-546. (Pubitemid 351804006)
10. Robles SC, Ferreccio C, Tsu V, et al. Assessing participation of women in a cervical cancer screening program in Peru. Rev Panam Salud Publica. 2009;25:189-195.
11. Almonte M, Ferreccio C, Winkler JL, et al. Cervical screening by visual inspection, HPV testing, liquid-based and conventional cytology in Amazonian Peru. Int J Cancer. 2007;121:796-802. (Pubitemid 47106209)
12. Cuschieri KS, Cubie HA, Whitley MW, et al. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol. 2004;57:68-72. (Pubitemid 38091314)
13. Hibbitts S, Rieck GC, Hart K, et al. Human papillomavirus infection: an anonymous prevalence study in South Wales, UK. Br J Cancer. 2006;95:226-232. (Pubitemid 44050922)
14. Kitchener HC, Almonte M, Wheeler P, et al. HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. Br J Cancer. 2006;95:56-61. (Pubitemid 43980554)
15. Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst. 2000;92:464-474. (Pubitemid 30182883)
16. Lazcano-Ponce E, Herrero R, Muñoz N, et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer. 2001;91:412-420. (Pubitemid 32049638)
17. Ferreccio C, Prado RB, Luzoro AV, et al. Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev. 2004;13:2271-2276. (Pubitemid 40054329)
18. Molano M, Posso H, Weiderpass E, et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer. 2002;87:324-333.
19. Khan MJ, Partridge EE, Wang SS, et al. Socioeconomic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer. 2005;104:61-70. (Pubitemid 40847753)
20. Franceschi S, Plummer M, Clifford G, et al. Differences in the risk of cervical cancer and human papillomavirus infection by education level. Br J Cancer. 2009;101:865-870.
21. Muñoz N, Franceschi S, Bosetti C, et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet. 2002;359:1093-1101. (Pubitemid 34270732)
22. Louie KS, de Sanjose S, Diaz M, et al. Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Br J Cancer. 2009;100: 1191-1197.
23. Almonte M, Murillo R, Sanchez GI, et al. New paradigms and challenges in cervical cancer prevention and control in Latin America. Salud Publica De Mexico. 2010;52:544-559.
24. Gage JC, Ferreccio C, Gonzales M, et al. Follow-up care of women with an abnormal cytology in a low-resource setting. Cancer Detect Prev. 2003;27:466-471. (Pubitemid 37506961)